National Syringe Services Program (SSP) Evaluation

Forms and Documents

Document Name	Status
Form 0920-21DC Nonresponse Survey Form and Instruction	New
Form 0920-21DC Survey Form and Instruction	New
Attachment 12_Sample Analysis Table.docx Supplementary Document	2021-07-16
Attachment 9_Project Determination.docx Supplementary Document	2021-07-13
Attachment 5_Model Final Reminder.docx Supplementary Document	2021-07-13
Attachment 4_Model Survey Reminders.docx Supplementary Document	2021-07-13
Attachment 3_Model Invitation Letter.docx Supplementary Document	2021-07-13
Attachment 2_60-Day FRN.pdf Supplementary Document	2021-07-13
Attachment 1_Authorizing Legislation.docx Supplementary Document	2021-07-13
Supporting Statement B.docx Supporting Statement B	2021-07-13
Supporting Statement_PartA_ 30 day_clean__2021_0701.docx Supporting Statement A	2021-07-13

IC Document Collections

IC ID	Document Title	Status
248418	Nonresponse Survey Form and Instruction	New
248417	Survey Form and Instruction	New

ICR Details

OMB Control No:	ICR Reference No: 202107-0920-003
Status: Received in OIRA	Previous ICR Reference No:
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-21DC
Title: National Syringe Services Program (SSP) Evaluation
Type of Information Collection: New collection (Request for a new OMB Control Number)	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 07/19/2021

	Requested	Previously Approved
Expiration Date	36 Months From Approved
Responses	960	0
Time Burden (Hours)	296	0
Cost Burden (Dollars)	0	0

---

Abstract: The National Syringe Services Program Evaluation (NSSPE) will be used to inform planning and evaluation of prevention programs that aim to reduce injection-related adverse health outcomes among people who inject drugs. The primary goals of the survey are to 1) assess and monitor syringe services programs (SSPs) operations and services, client characteristics and drug use patterns, funding resources, community relations, and key operational and programmatic successes and challenges, and 2) support timely analysis and dissemination of national program evaluation survey findings. CDC will work with an award recipient and North American Syringe Exchange Network (NASEN) to conduct annual surveys.

---

Authorizing Statute(s): US Code: 42 USC 241 Name of Law: PHSA
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	86 FR 11532	02/25/2021
30-day Notice:	Federal Register Citation:	Citation Date:
	86 FR 38096	07/19/2021
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 2

IC Title	Form No.	Form Name
Nonresponse Survey	0920-21DC	Nonresponse Survey
Survey	0920-21DC, 0920-21DC	Survey Year One ,   Survey Year Two/Three

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	960	0	0	960	0	0
Annual Time Burden (Hours)	296	0	0	296	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: This is a New collection.

---

Annual Cost to Federal Government: $278,996

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 07/19/2021

---